PlantArc Bio Past Earnings Performance
Past criteria checks 0/6
PlantArc Bio's earnings have been declining at an average annual rate of -19.8%, while the Biotechs industry saw earnings growing at 11.1% annually. Revenues have been growing at an average rate of 155.6% per year.
Key information
-19.8%
Earnings growth rate
52.3%
EPS growth rate
| Biotechs Industry Growth | -24.5% |
| Revenue growth rate | 155.6% |
| Return on equity | -28.0% |
| Net Margin | -161.2% |
| Last Earnings Update | 30 Jun 2023 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses BreakdownBeta
How PlantArc Bio makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 23 | 2 | -4 | 2 | 3 |
| 31 Mar 23 | 1 | -4 | 2 | 3 |
| 31 Dec 22 | 0 | -5 | 2 | 3 |
| 30 Sep 22 | 0 | -5 | 2 | 3 |
| 30 Jun 22 | 0 | -5 | 2 | 3 |
| 31 Mar 22 | 0 | -6 | 2 | 4 |
| 31 Dec 21 | 0 | -6 | 2 | 4 |
| 30 Sep 21 | 0 | -6 | 2 | 3 |
| 30 Jun 21 | 0 | -5 | 2 | 3 |
| 31 Mar 21 | 0 | -3 | 1 | 2 |
| 31 Dec 20 | 0 | -2 | 0 | 2 |
| 30 Sep 20 | 0 | -2 | 0 | 2 |
| 30 Jun 20 | 0 | -2 | 0 | 2 |
| 31 Mar 20 | 0 | -2 | 0 | 2 |
| 31 Dec 19 | 0 | -2 | 0 | 2 |
| 31 Dec 18 | 0 | -3 | 1 | 2 |
Quality Earnings: PLNT is currently unprofitable.
Growing Profit Margin: PLNT is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: PLNT is unprofitable, and losses have increased over the past 5 years at a rate of 19.8% per year.
Accelerating Growth: Unable to compare PLNT's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: PLNT is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-2.3%).
Return on Equity
High ROE: PLNT has a negative Return on Equity (-28.05%), as it is currently unprofitable.